Bluejay Diagnostics, Inc. (BJDX)Healthcare | Medical Devices | Acton, United States | NasdaqCM
2.00 USD
+0.06
(3.093%)
⇧
(April 17, 2026, 4 p.m.
EDT)
After hours: 2.04 +0.04 (2.000%) ⇧ (April 17, 2026, 7:54 p.m. EDT) Short-term: ☆☆☆☆☆ | Long-term: ☆☆☆☆☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 19, 2026, 12:17 a.m. EDT
Avoid. Fundamentals show severe distress with losses on assets and equity, yet the 45-day forecasting model projects a -37% price decline. While a reverse split and positive near-term sepsis test progress offer a minor narrative hook, the liquidity is likely constricted post-split, and the stock remains significantly detached from book value. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.110621 |
| AutoARIMA | 0.161237 |
| AutoETS | 0.349874 |
| MSTL | 0.359824 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 80% |
| H-stat | 0.77 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.287 |
| Excess Kurtosis | -1.06 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 2.168 |
| Market Cap | 2,069,430 |
| Forward P/E | -6.25 |
| Beta | 0.67 |
| Website | https://bluejaydx.com |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.7076024 |
| Address1 | 360 Massachusetts Avenue |
| Address2 | Suite 203 |
| All Time High | 200,000.0 |
| All Time Low | 1.649 |
| Ask | 2.48 |
| Ask Size | 2 |
| Average Daily Volume10 Day | 16,810 |
| Average Daily Volume3 Month | 221,444 |
| Average Volume | 221,444 |
| Average Volume10Days | 16,810 |
| Beta | 0.673 |
| Bid | 1.4 |
| Bid Size | 2 |
| Book Value | 9.884 |
| City | Acton |
| Compensation As Of Epoch Date | 1,735,603,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 2.0 |
| Current Ratio | 4.882 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 2.01 |
| Day Low | 1.86 |
| Debt To Equity | 2.168 |
| Display Name | Bluejay Diagnostics |
| Ebitda | -6,842,535 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | 0.452 |
| Enterprise Value | -3,090,887 |
| Eps Forward | -0.32 |
| Eps Trailing Twelve Months | -15.25 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 2.1229 |
| Fifty Day Average Change | -0.12290001 |
| Fifty Day Average Change Percent | -0.05789251 |
| Fifty Two Week Change Percent | -70.76024 |
| Fifty Two Week High | 16.68 |
| Fifty Two Week High Change | -14.68 |
| Fifty Two Week High Change Percent | -0.8800959 |
| Fifty Two Week Low | 1.649 |
| Fifty Two Week Low Change | 0.35099995 |
| Fifty Two Week Low Change Percent | 0.21285625 |
| Fifty Two Week Range | 1.649 - 16.68 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,636,554,600,000 |
| Float Shares | 852,156 |
| Forward Eps | -0.32 |
| Forward P E | -6.25 |
| Free Cashflow | -3,706,221 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 6 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.0 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.051799998 |
| Held Percent Institutions | 0.040700004 |
| Implied Shares Outstanding | 1,034,715 |
| Industry | Medical Devices |
| Industry Disp | Medical Devices |
| Industry Key | medical-devices |
| Ipo Expected Date | 2,021-11-10 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,769,644,800 |
| Last Split Factor | 1:4 |
| Long Business Summary | Bluejay Diagnostics, Inc. operates as a medical diagnostics company. It offers Symphony technology platform which consists of an analyzer and single-use protein detection cartridges that are designed to provide measurements of key diagnostic biomarkers found in blood; and Symphony analyzer used to orchestrate sample processing of whole blood, plasma, serum, etc., biomarker isolation, and immunoassay preparation using non-contact centrifugal force. The company also develops Symphony IL-6 tests for the monitoring of disease progression in critical care settings. In addition, it develops additional tests for Symphony, such as tests for myocardial infraction and congestive heart failure, as well as other tests using the Symphony platform. Bluejay Diagnostics, Inc. was incorporated in 2015 and is headquartered in Acton, Massachusetts. |
| Long Name | Bluejay Diagnostics, Inc. |
| Market | us_market |
| Market Cap | 2,069,430 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_384143134 |
| Most Recent Quarter | 1,767,139,200 |
| Net Income To Common | -6,848,483 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 2,069,430 |
| Open | 1.94 |
| Operating Cashflow | -6,053,575 |
| Operating Margins | 0.0 |
| Payout Ratio | 0.0 |
| Phone | 844 327 7078 |
| Post Market Change | 0.03999996 |
| Post Market Change Percent | 1.9999981 |
| Post Market Price | 2.04 |
| Post Market Time | 1,776,470,064 |
| Previous Close | 1.94 |
| Price Hint | 4 |
| Price To Book | 0.20234723 |
| Profit Margins | 0.0 |
| Quick Ratio | 4.615 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | 0.0599999 |
| Regular Market Change Percent | 3.09278 |
| Regular Market Day High | 2.01 |
| Regular Market Day Low | 1.86 |
| Regular Market Day Range | 1.86 - 2.01 |
| Regular Market Open | 1.94 |
| Regular Market Previous Close | 1.94 |
| Regular Market Price | 2.0 |
| Regular Market Time | 1,776,456,000 |
| Regular Market Volume | 6,246 |
| Return On Assets | -0.62758 |
| Return On Equity | -1.1702 |
| Sand P52 Week Change | 0.38150132 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 1,034,715 |
| Shares Percent Shares Out | 0.041500002 |
| Shares Short | 42,958 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 37,152 |
| Short Name | Bluejay Diagnostics, Inc. |
| Short Percent Of Float | 0.041500002 |
| Short Ratio | 1.24 |
| Source Interval | 15 |
| State | MA |
| Symbol | BJDX |
| Total Cash | 5,164,875 |
| Total Cash Per Share | 5.312 |
| Total Debt | 129,558 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -15.25 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 4.868425 |
| Two Hundred Day Average Change | -2.868425 |
| Two Hundred Day Average Change Percent | -0.5891895 |
| Type Disp | Equity |
| Volume | 6,246 |
| Website | https://bluejaydx.com |
| Zip | 1,720 |